Company Synovics Pharmaceuticals, Inc. Other OTC
Equities
SYVC
US87163M1018
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2007 | Weight | 2008 | Weight | Delta |
---|---|---|---|---|---|
Health Products
100.0
%
| 23 | 100.0 % | 26 | 100.0 % | +10.62% |
Sales per region
USD in Million | 2007 | Weight | 2008 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 23 | 100.0 % | 26 | 100.0 % | +10.62% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 28,955 | 0 | 0 | 95.75 % |
Stock B | 1 | 31,152,354 | 29,827,357 ( 95.75 %) | 1,324,997 ( 4.253 %) | |
Stock C | 0 | 591,850 | 0 | 0 |
Company contact information
Synovics Pharmaceuticals, Inc.
5360 Northwest 35th Avenue
33309, Fort Lauderdale
+
Sector
1st Jan change | Capi. | |
---|---|---|
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |